Objective: To determine the initial clinical status and the long-term outcome of mothers and
their children with autoantibody-associated congenital heart block. Design: Dynamic …

Objectives. The present study describes the demographics, mortality, morbidity and
recurrence rates of autoimmune-associated congenital heart block (CHB) using information …

One of the strongest associations with autoantibodies directed to components of the SSA/Ro‐
SSB/La ribonucleoprotein complex is the development of congenital heart block (CHB) in an …

Objective. To study the long-term outcome of mothers of children with isolated congenital
heart block (CHB) and to characterize the maternal autoantibody response to SS-A/Ro and …

OBJECTIVES: To determine the health of mothers of offspring with complete congenital
heart block (CHB) both at the time of delivery of the affected child and in the long-term, and …

Nearly a century ago, Morquio first described the rare defect of isolated congenital heart
block (CHB). 86 In 1928, Aylward reported the occurrence of CHB in two children whose …

Neonatal lupus syndrome is a model of passively acquired autoimmunity in which the
pregnant woman's serum contains specific antibodies to 52 or 60 kd SSA/Ro and/or 48 kd …

When anti-SSA/Ro antibodies are present in sera of mothers with connective tissue
diseases, the incidence of congenital heart block (CHB) has been reported to be 1-2% in …

Background Cardiac neonatal lupus syndrome is due to anti-SSA or SSB antibodies and
mainly includes congenital heart block (CHB) and dilated cardiomyopathy (DCM). Its optimal …

Objective The recurrence rate of anti‐SSA/Ro–associated congenital heart block (CHB) is
17%. Sustained reversal of third‐degree block has never been achieved. Based on potential …